Get the Stockscreener App
5.87
6.53%
0.36
After Hours:
5.85
-0.02
-0.34%
Cumberland Pharmaceuticals Inc stock is traded at $5.87, with a volume of 118.06K.
It is up +6.53% in the last 24 hours and up +92.46% over the past month.
Cumberland Pharmaceuticals Inc is a specialty pharmaceutical company focused on the acquisition, development, and commercialization of branded prescription pharmaceutical products. The Company has one operating segment, which is specialty pharmaceutical products. The company's target markets are hospital acute care, gastroenterology, rheumatology, and oncology. The firm promotes its approved products through its hospital, field, and oncology sales divisions in the United States and establishes a network of international partners to register and provide medicines to patients in their countries. Its brands include Acetadote, Caldolor, Kristalose, Sancuso, Vaprisol, and Vibativ. Geographically, the company generates revenue from China, South Korea, Russia, Mexico, Australia, and Saudi Arabia.
See More
Previous Close:
$5.51
Open:
$5.44
24h Volume:
118.06K
Relative Volume:
0.13
Market Cap:
$87.95M
Revenue:
$44.52M
Net Income/Loss:
$-2.86M
P/E Ratio:
-30.70
EPS:
-0.1912
Net Cash Flow:
$4.75M
1W Performance:
+7.31%
1M Performance:
+92.46%
6M Performance:
+195.72%
1Y Performance:
+15.32%
1-Day Range:
$5.44
$5.96
1-Week Range:
$5.03
$5.96
52-Week Range:
$1.85
$6.265
Cumberland Pharmaceuticals Inc Stock (CPIX) Company Profile
Name
Cumberland Pharmaceuticals Inc
Sector
Phone
615-255-0068
Address
1600 WEST END AVENUE, NASHVILLE,, TN
Compare CPIX vs TAK, HLN, TEVA, ZTS, UTHR
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
CPIX
Cumberland Pharmaceuticals Inc
|
5.87 | 82.56M | 44.52M | -2.86M | 4.75M | -0.1912 |
TAK
Takeda Pharmaceutical Co Adr
|
16.25 | 52.07B | 29.91B | 1.30B | 3.49B | 0.4056 |
HLN
Haleon Plc Adr
|
9.29 | 41.28B | 14.54B | 2.22B | 2.58B | 0.4871 |
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
34.07 | 39.78B | 17.53B | 1.58B | 444.18M | 1.3457 |
ZTS
Zoetis Inc
|
81.32 | 33.57B | 9.51B | 2.64B | 2.14B | 6.0361 |
UTHR
United Therapeutics Corp
|
568.43 | 24.02B | 3.17B | 1.29B | 1.01B | 27.09 |
Cumberland Pharmaceuticals Inc Stock (CPIX) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Nov-12-12 | Reiterated | UBS | Neutral |
| Feb-01-11 | Reiterated | UBS | Neutral |
| Dec-16-10 | Downgrade | UBS | Buy → Neutral |
| Aug-17-10 | Downgrade | Jefferies | Buy → Hold |
| Aug-17-10 | Reiterated | Morgan Joseph | Buy |
| Aug-17-10 | Reiterated | UBS | Buy |
| May-14-10 | Reiterated | Morgan Joseph | Buy |
View All
Cumberland Pharmaceuticals Inc Stock (CPIX) Latest News
Cumberland Pharmaceuticals jumps on $100M Apotex transaction - MSN
Cumberland Pharmaceuticals (CPIX) to sell U.S. brands to Apotex for $100M - Stock Titan
Cumberland outlines $100M Apotex deal while shifting to development-focused strategy - MSN
Cumberland Pharmaceuticals Inc. Q1 2026 Financial Results: Revenue, Expenses, and Company Overview - Minichart
$100M Apotex deal to reshape Cumberland (CPIX) into development player - Stock Titan
MSN Money - MSN
What Cumberland (CPIX) does that creates lasting value (Slight Dip) 2026-05-08Trade Entry Signals - Newser
Cumberland Pharmaceuticals Inc. (NASDAQ:CPIX) Q1 2026 Earnings Call Transcript - Insider Monkey
Cumberland Pharmaceuticals Divests US Portfolio to Apotex for $100 Million - HarianBasis.co
Cumberland Pharmaceuticals Pivots After Transformational Apotex Deal - TipRanks
Cumberland Posts Loss in Q1 Amid $100M Apotex Deal Plan - Yahoo Finance
Cumberland Pharmaceuticals Inc. Q1 2026 Earnings Call Summary - Yahoo Finance
Cumberland: Q1 Earnings Snapshot - theheraldreview.com
Cumberland Pharmaceuticals (NASDAQ:CPIX) Issues Earnings Results - MarketBeat
Cumberland Pharmaceuticals Sells FDA-Approved Brands for $100 Million to Apotex, Reports Q1 2026 Financial Results and Focuses on Orphan Drug Pipeline 1 - Minichart
Cumberland Pharmaceuticals Q1 Earnings Call Highlights - MarketBeat
Cumberland Pharmaceuticals Q1 revenue up 5%; to sell FDA‑approved brands to Apotex for $100 mln - TradingView
Cumberland Pharmaceuticals Inc. (CPIX) Stock Falls on Q1 2026 Earnings - Quiver Quantitative
CPIX: $100M Apotex deal and FDA approvals mark a strategic pivot to pipeline innovation - TradingView
Earnings call transcript: Cumberland Pharmaceuticals Q1 2026 shows mixed results - Investing.com
Cumberland Pharmaceuticals reports Q1 2026: $9.1M revenue, $3.3M net loss, Strategic Transaction announced - TradingView
Full Transcript: Cumberland Q1 2026 Earnings Call - Benzinga
Cumberland Pharmaceuticals (CPIX) sets $100M brand sale as Q1 2026 turns to loss - Stock Titan
$100M Apotex deal would leave Cumberland focused on orphan drugs - Stock Titan
CUMBERLAND PHARMACEUTICALS REPORTS Q1 2026 FINANCIAL RESULTS & COMPANY UPDATE - Yahoo Finance
Apotex Affiliate to Acquire Cumberland Pharmaceutical Portfolio for $100M - HarianBasis.co
Cumberland Pharmaceuticals (CPIX) Integrates Commercial Business with Apotex - Insider Monkey
Q&A: A.J. Kazimi, Cumberland Pharmaceuticals - Nashville Post
Cumberland Pharmaceuticals (CPIX.US) will release its earnings report after the market closes on May 5. - Moomoo
CUMBERLAND PHARMACEUTICALS TO ANNOUNCE Q1 2026 FINANCIAL RESULTS & COMPANY UPDATE - Weekly Voice
After the bell May 5: Cumberland to host Q1 update at 4:30 ET - Stock Titan
Cumberland Pharmaceuticals (CPIX) Expected to Announce Earnings on Tuesday - MarketBeat
RedHill Biopharma Announces Full-Year 2025 Financial Results and Operational Highlights - Sahm
Cumberland Shareholders Back Board, Auditor and Pay Policies - The Globe and Mail
Cumberland Pharmaceuticals Inc. Files 8-K Report with SEC Detailing Company Information and Shareholder Vote Results - Minichart
Cumberland Pharmaceuticals (NASDAQ:CPIX) Stock Price Passes Above 200 Day Moving AverageHere's What Happened - MarketBeat
Cumberland Pharmaceuticals shareholders approve board nominees and other proposals - Investing.com
Cumberland Pharmaceuticals Shares Surge 80 Percent After Apotex Deal - HarianBasis.co
Shareholders at Cumberland (NASDAQ: CPIX) back board, auditor and pay - Stock Titan
Crude Oil Gains Over 1%; US Initial Jobless Claims Edge Higher - Sahm
Apotex inks strategic transaction with Cumberland Pharma - The Pharma Letter
Baker Donelson Represents Cumberland Pharmaceuticals in Strategic Transaction to Integrate Commercial Business with Apotex - Baker Donelson
Cumberland to sell drug portfolio to Apotex for $100m - Pharmaceutical Technology
Cumberland Pharmaceuticals stock soars on $100M Apotex deal By Investing.com - Investing.com South Africa
CPIX Price Today: Cumberland Pharmaceuticals Inc. Stock Price, Quote & Chart | MEXC - MEXC Exchange
Cumberland shares soar on $100M deal announcement - Nashville Post
Cumberland Pharmaceuticals Inc Stock (CPIX) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.92%
4.44%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):